VYNE Therapeutics Earnings Perspective: Return On Capital Employed
September 09, 2022 at 10:16 AM EDT
VYNE Therapeutics (NASDAQ:VYNE) brought in sales totaling $126 thousand during Q2 according to data provided by Benzinga Pro. However, ...